Pricing

BIRCHVIEW CAPITAL, LP

0 followers ·
BURLINGTON VT Investment Advisor Hedge Fund
13F Summary

Subscription Required

Equal-WT
WhaleScore 2.0 ?

85

S&P 500
WhaleScore ?

Subscription Required

Equal-WT
WhaleScore 1.0 ?

Birchview Capital is based out of Burlington. Birchview Capital is a hedge fund with 12 clients and discretionary assets under management (AUM) of $210,506,714 (Form ADV from 2023-08-21). Their last reported 13F filing for Q4 2023 included $127,549,846 in managed 13F securities and a top 10 holdings concentration of 70.36%. Birchview Capital's largest holding is Bristol-Myers Squibb Co with shares held of 702,298. Whalewisdom has at least 47 13F filings, 2 13D filings, and 9 13G filings

2023-12-31

Top Buys (13F)

2023-12-31

Top Sells (13F)

Name % Change
BMY Bristol-Myers Squibb 7.13%
BLUE Bluebird Bio Inc 0.83%
KPTI Karyopharm Therapeut 0.33%
TSVT 2seventy bio Inc 0.13%
GOSS Gossamer Bio Inc 0.05%

2023-12-31

13F Holdings Summary

Name $ Change
BMY Bristol-Myers Squibb 28.25%
NBIX Neurocrine Bioscienc 7.98%
BDSX Biodesix, Inc. 7.47%
ACAD Acadia Pharmaceutica 5.9%
PRTA Prothena Corp PLC 4.83%

2023-12-31

13F Activity

Market Value $128m, Prior: $117m
New Purchases 8 stocks
Added To 11 stocks
Sold out of 1 stocks
Reduced holdings in 8 stocks
Top 10 Holdings % 70.36%
Turnover %[1] 15.52%
Turnover Alt %[2] 1.63%
Time Held Top 20 10.8 quarters
Time Held Top 10 10.7 quarters
Time Held All 13.83 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2023-12-31

13F Sector Allocation Over Time

2023-12-31

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2023-12-31

Portfolio Performance